Pulsenmore Expands Its U.S. Footprint with TLC Partnership
Pulsenmore Ltd. (NASDAQ: PLSM), a leading innovator in home ultrasound technology, has recently made strides in the U.S. healthcare market. Their latest commercial engagement is with TLC Perinatal PA, a well-regarded maternal-fetal medicine and women's ultrasound practice. This partnership marks a significant step in Pulsenmore's expansion strategy as they introduce their services across the United States.
Transforming Prenatal Care
In February 2026, Pulsenmore's U.S. subsidiary finalized a services agreement with TLC Perinatal PA, which operates in suburban Maryland. Through this agreement, TLC Perinatal will integrate Pulsenmore's Early Screening home ultrasound services into their care model. This innovative approach allows expectant mothers to conduct ultrasound scans in the comfort of their homes, while still receiving physician-directed care through a blend of telehealth and traditional clinic visits.
Enhancing Patient Experience
The collaboration is a response to the growing interest among U.S. healthcare providers in patient-centric technologies. By utilizing Pulsenmore's home ultrasound services, clinicians can offer a more flexible and continuous care pathway. This setup not only encourages patients to engage more actively in monitoring their own health but also allows healthcare providers to maintain oversight in their care.
About TLC Perinatal PA
TLC Perinatal PA specializes in maternal-fetal medicine, emphasizing diagnostic imaging and consultative care for pregnancies. Led by Medical Director Dr. Richard Broth, the practice oversees approximately 2,000 pregnancies each year across its two locations. They are recognized for their commitment to incorporating new technologies into prenatal care, demonstrating a progressive approach within the healthcare sector.
Commitment to Innovation
Dr. Broth expressed enthusiasm about the integration of Pulsenmore’s technology, stating, "This collaboration underscores our dedication to advancing access to prenatal care while enhancing convenience for our patients. The adoption of such technology falls in line with ACOG's 2025 Clinical Consensus, fostering remote monitoring of fetal health and refining care delivery by personalizing services and minimizing visits without causing any reduction in care quality."
Leadership Views on U.S. Engagement
Dr. Elazar Sonnenschein, CEO of Pulsenmore, shared his insights on the U.S. market entry and their strategic goals. He remarked that the engagement with TLC Perinatal reflects strong interest from healthcare practices committed to innovation. This collaboration is aimed at demonstrating how maternal-fetal medicine teams can deftly integrate home ultrasound technology into their existing clinical frameworks, ultimately benefiting patients through enhanced care flexibility without compromising physician oversight.
About Pulsenmore
Pulsenmore is dedicated to revolutionizing maternal health by developing cutting-edge home-use ultrasound technologies that ensure a seamless connection between mothers and healthcare providers. Their solutions harness advanced imaging and telemedicine to make prenatal care more patient-centric, ultimately broadening access and ensuring continuity of care. For more details about their offerings, visit their official website.
Frequently Asked Questions
What is the significance of Pulsenmore’s partnership with TLC Perinatal PA?
This partnership represents a step forward in integrating patient-friendly technologies into prenatal care, enabling expectant mothers to conduct ultrasound scans from home.
How does Pulsenmore’s technology enhance maternal health?
Pulsenmore's home ultrasound services facilitate remote monitoring of fetal health, providing flexibility and continuity of care while allowing for physician oversight.
Who is leading TLC Perinatal PA?
Dr. Richard Broth, as Medical Director, leads TLC Perinatal, ensuring that the practice remains at the forefront of technology integration in maternal-fetal medicine.
How many pregnancies does TLC Perinatal manage annually?
TLC Perinatal PA manages around 2,000 pregnancies each year at its two Maryland locations.
What are the future aspirations for Pulsenmore in the U.S. market?
Pulsenmore aims to solidify its position in the U.S. healthcare market by continuing to innovate and expand its home ultrasound services, supporting maternal health across multiple healthcare practices.
